Antimicrobial Peptides and Physical Activity: A Great Hope against COVID 19
Open Access
- 30 June 2021
- journal article
- review article
- Published by MDPI AG in Microorganisms
- Vol. 9 (7), 1415
- https://doi.org/10.3390/microorganisms9071415
Abstract
Antimicrobial peptides (AMPs), α- and β-defensins, possess antiviral properties. These AMPs achieve viral inhibition through different mechanisms of action. For example, they can: (i) bind directly to virions; (ii) bind to and modulate host cell-surface receptors, disrupting intracellular signaling; (iii) function as chemokines to augment and alter adaptive immune responses. Given their antiviral properties and the fact that the development of an effective coronavirus disease 2019 (COVID-19) treatment is an urgent public health priority, they and their derivatives are being explored as potential therapies against COVID-19. These explorations using various strategies, range from their direct interaction with the virus to using them as vaccine adjuvants. However, AMPs do not work in isolation, specifically in their role as potent immune modulators, where they interact with toll-like receptors (TLRs) and chemokine receptors. Both of these receptors have been shown to play roles in COVID-19 pathogenesis. In addition, it is known that a healthy lifestyle accompanied by controlled physical activity can represent a natural weapon against COVID-19. In competitive athletes, an increase in serum defensins has been shown to function as self-protection from the attack of microorganisms, consequently a controlled physical activity could act as a support to any therapies in fighting COVID-19. Therefore, including information on all these players’ interactions would produce a complete picture of AMP-based therapies’ response.Keywords
This publication has 145 references indexed in Scilit:
- The Human Cathelicidin LL-37 Has Antiviral Activity against Respiratory Syncytial VirusPLOS ONE, 2013
- Antibacterial Effect of Human Mesenchymal Stem Cells Is Mediated in Part from Secretion of the Antimicrobial Peptide LL-37The International Journal of Cell Cloning, 2010
- Structures of influenza A proteins and insights into antiviral drug targetsNature Structural & Molecular Biology, 2010
- Expression of human β-defensin-2 in intratumoral vascular endothelium and in endothelial cells induced by transforming growth factor βPeptides, 2010
- Rhesus Theta-Defensin Prevents Death in a Mouse Model of Severe Acute Respiratory Syndrome Coronavirus Pulmonary DiseaseJournal of Virology, 2009
- Coronaviruses post-SARS: update on replication and pathogenesisNature Reviews Microbiology, 2009
- Demographic Differences and Trends of Vitamin D Insufficiency in the US Population, 1988-2004JAMA Internal Medicine, 2009
- The Host Defense Peptide LL-37 Selectively Permeabilizes Apoptotic LeukocytesAntimicrobial Agents and Chemotherapy, 2009
- The spike protein of SARS-CoV — a target for vaccine and therapeutic developmentNature Reviews Microbiology, 2009
- Role of Human β-Defensin-2 during Tumor Necrosis Factor-α/NF-κB-mediated Innate Antiviral Response against Human Respiratory Syncytial VirusOnline Journal of Public Health Informatics, 2008